Further Debate on T3 + T4 Combination Therapy at ATA Meeting Further Debate on T3 + T4 Combination Therapy at ATA Meeting

The 89th annual meeting gets underway this week, with anaplastic thyroid cancer guidelines and combination T3 /T4 therapy among the highlights being discussed.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news